Vertex Pharmaceuticals, Inc. VRTX

NAS: VRTX | ISIN: US92532F1003   24/12/2024
408,18 USD (+0,72%)
(+0,72%)   24/12/2024

BetterInvesting™ Magazine Update on Vertex Pharmaceuticals Inc. and Martin Marietta Materials Inc.

TROY, Mich., Jan. 10, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) as its "Stock to Study" and Martin Marietta Materials Inc. (NYSE: MLM) as its "Undervalued Stock" in the March 2024 issue for investors' informational and educational use.

"The S&P500 Index notched a total return gain of more than 26% in 2023, although a small number of individual stocks had an outsize influence over the index," said Ken Zendel, CEO of National Association of Investors, the parent organization of BetterInvesting. "Learning how to identify and understand individual stocks and the fundamental reasons for their performance lie at the heart of BetterInvesting's mission."

To learn more, visit https://www.betterinvesting.org/find-great-stocks/online-tools.

Check the March 2024 issue of BetterInvesting Magazine for more details about the latest stocks. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of Vertex Pharmaceuticals Inc. and Martin Marietta Materials Inc. by viewing their fundamental data and applying judgments.

Committee members are Lauren Adams, CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; and Anne Nichols, CFA.

As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

About BetterInvesting:

BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org.

Follow us on LinkedIn and Facebook.

Contact: 877-275-6242

Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-vertex-pharmaceuticals-inc-and-martin-marietta-materials-inc-302031888.html

SOURCE NAIC-BetterInvesting

Vertex Pharmaceuticals, Inc. in het nieuws

Mijn selecties